HNB
CYTK icon

Huntington National Bank’s Cytokinetics CYTK Stock Holding History

Huntington National Bank’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20K Hold
303
– – ﹤0.01% 1652
2025
Q4 		$19.3K Buy
303
+8
+3% +$498 ﹤0.01% 1599
2025
Q3 		$16.2K Sell
295
-27
-8% -$1.11K ﹤0.01% 1671
2025
Q2 		$10.6K Buy
322
+195
+154% +$6.78K ﹤0.01% 1776
2025
Q1 		$5.1K Buy
127
+11
+9% +$506 ﹤0.01% 1975
2024
Q4 		$5.46K Sell
116
-34
-23% -$1.77K ﹤0.01% 1973
2024
Q3 		$7.92K Buy
150
+36
+32% +$2.01K ﹤0.01% 1841
2024
Q2 		$6.18K Sell
114
-130
-53% -$7.85K ﹤0.01% 1860
2024
Q1 		$17.1K Buy
244
+48
+24% +$3.71K ﹤0.01% 1519
2023
Q4 		$16.4K Sell
196
-53
-21% -$1.92K ﹤0.01% 1481
2023
Q3 		$7.34K Sell
249
-16
-6% -$533 ﹤0.01% 1676
2023
Q2 		$8.64K Sell
265
-95
-26% -$3.52K ﹤0.01% 1610
2023
Q1 		$12.7K Buy
360
+47
+15% +$1.92K ﹤0.01% 1461
2022
Q4 		$14.3K Buy
313
+75
+32% +$3.23K ﹤0.01% 1386
2022
Q3 		$12K Hold
238
– – ﹤0.01% 1471
2022
Q2 		$9K Hold
238
– – ﹤0.01% 1596
2022
Q1 		$9K Buy
238
+6
+3% +$213 ﹤0.01% 1627
2021
Q4 		$11K Buy
232
+1
+0.4% +$39 ﹤0.01% 1548
2021
Q3 		$8K Sell
231
-125
-35% -$3.68K ﹤0.01% 1487
2021
Q2 		$7K Buy
356
+30
+9% +$704 ﹤0.01% 1506
2021
Q1 		$8K Buy
+326
New +$6.96K ﹤0.01% 1373
2014
Q1 		– Sell
-151
Closed – – 1255
2013
Q4 		$0 Hold
151
– – ﹤0.01% 1716
2013
Q3 		$1K Buy
151
+45
+42% +$483 ﹤0.01% 1707
2013
Q2 		$1K Buy
+106
New +$835 ﹤0.01% 1688

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Huntington National Bank's CYTK Position: Q1 2026 in Review

Huntington National Bank held its Cytokinetics (CYTK) position steady in Q1 2026 at 303 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #1652.

Huntington National Bank first reported a position in CYTK in Q2 2013 and has held it in 24 quarters since. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Huntington National Bank held 303 shares of Cytokinetics worth $20K as of Q1 2026.
  • Huntington National Bank left its Cytokinetics share count unchanged in Q1 2026.
  • Cytokinetics made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #1652 holding.
  • Huntington National Bank first reported a position in Cytokinetics in Q2 2013 and has held it in 24 quarters since.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.